A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization.
Phosphoglycerate kinase (PGK) is a key glycolytic enzyme that catalyzes the reversible phosphotransfer reaction from 1,3-bisphosphoglycerate to MgADP, to form 3-phosphoglycerate and MgATP. Two isozymes encoded by distinct genes are present in humans: PGK-1, located on Xq-13.3, encodes a ubiquitous protein of 417 amino acids, whereas PGK-2 is testis-specific. PGK1 deficiency is characterized by mild to severe hemolytic anemia, neurological dysfunctions and myopathy; patients rarely exhibit all three clinical features. Nearly 40 cases have been reported, 27 of them characterized at DNA or protein level, and 20 different mutations were described. Here we report the first Italian case of PGK deficiency characterized at a molecular and biochemical level. The patient presented during infancy with hemolytic anemia, increased CPK values, and respiratory distress; the study of red blood cell enzymes showed a drastic reduction in PGK activity. In adulthood he displayed mild hemolytic anemia, mental retardation and severe myopathy. PGK-1 gene sequencing revealed the new missense mutation c.1112T>A (p.Ile371Lys). The mutation was not found among 100 normal alleles, and even if located in the third to the last nucleotide of exon 9, it did not alter mRNA splicing. The p.Ile371Lys mutation falls in a conserved region of the enzyme, near the nucleotide binding site. The mutant enzyme shows reduced catalytic rates toward both substrates (apparent k(cat) values, 12-fold lower than wild-type) and a decreased affinity toward MgATP (apparent K(m), 6-fold higher than wild-type). Moreover, it lost half of activity after nearly 9-min incubation at 45°C, a temperature that did not affect the wild-type enzyme (t(1/2)>1 h). The possible compensatory expression of PGK2 isoenzyme was investigated in the proband and in the heterozygote healthy sisters, and found to be absent. Therefore, the highly perturbed catalytic properties of the new variant p.Ile371Lys, combined with protein instability, account for the PGK deficiency found in the patient and correlate with the clinical expression of the disease.
UO Ematologia e Centro Trapianti di Midollo, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy.
Elisa
E
Fermo
Paola
P
Bianchi
Laurent Roberto
LR
Chiarelli
Maristella
M
Maggi
Giuseppa Maria Luana
GM
Mandarà
Cristina
C
Vercellati
Anna Paola
AP
Marcello
Wilma
W
Barcellini
Agostino
A
Cortelezzi
Giovanna
G
Valentini
Alberto
A
Zanella
D000328:Adult; D000595:Amino Acid Sequence; D002675:Child, Preschool; D004789:Enzyme Activation; D004795:Enzyme Stability; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D040181:Genetic Diseases, X-Linked / Q000201:enzymology* / Q000235:genetics*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008661:Metabolism, Inborn Errors / Q000201:enzymology* / Q000235:genetics*; D008969:Molecular Sequence Data; D050505:Mutant Proteins / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D009928:Organ Specificity / Q000235:genetics*; D010375:Pedigree; D010735:Phosphoglycerate Kinase / Q000737:chemistry / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism
D007527:Isoenzymes; D050505:Mutant Proteins; D012333:RNA, Messenger; D010735:Phosphoglycerate Kinase; C104317:phosphoglycerate kinase, testis specific